Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Thorax|April 9, 2018
Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nucleiMichelle E Wood, Rebecca E Stockwell, Graham R Johnson, et al.
The Lancet. Child & Adolescent Health|May 16, 2025
Insulin for early glycaemic abnormality in children with cystic fibrosis without cystic fibrosis-related diabetes (CF-IDEA): a randomised controlled trialShihab Hameed, Elizabeth H Barnes, Julie Briody, et al.
The European Respiratory Journal|January 18, 2020
Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohortNaomi E Wijker, Suzanna Vidmar, Keith Grimwood, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2026
Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosisAbdullah A Tarique, Stefan Emming, Dean Kelk, et al.
Clinical Chemistry|August 19, 2007
Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patientsBrendan J McMorran, Severine A Ouvry Patat, John B Carlin, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2025
Infection by Clonally Related Mycobacterium abscessus Isolates: The Role of Drinking WaterRachel M Thomson, Nicole Wheeler, Rebecca E Stockwell, et al.
The Lancet. Respiratory Medicine|December 23, 2021
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trialSivagurunathan Sutharsan, Edward F McKone, Damian G Downey, et al.
The New England Journal of Medicine|November 4, 2011
A CFTR potentiator in patients with cystic fibrosis and the G551D mutationBonnie W Ramsey, Jane Davies, N Gerard McElvaney, et al.
Thorax|January 28, 2021
Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in AustraliaRoxanne Strachan, Nusrat Homaira, Sean Beggs, et al.
The New England Journal of Medicine|May 19, 2015
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTRClaire E Wainwright, J Stuart Elborn, Bonnie W Ramsey, et al.
Pageof 20